Help CenterThis page provides links to every currently open campaign*, letting you view industry calls for opportunities and requests for proposals. Click on the links to see a full pdf overview of what these companies are looking for. You can use this page to share details on these campaigns with colleagues and researchers at your institute, even if they haven't registered for an Inpart account yet.
Seeking Novel Therapeutics with Utility in CNS and PNS Indications - Anon
Closes 7th April 2026
Seeking Proteases as Inhibitory Targets for Disease Treatment - Daiichi Sankyo
Closes 30th March 2026
Seeking Vaccine Candidates with Cross-protection Against Canine Leptospira - Anon
Closes 30th March 2026
Drug Delivery Platforms: Novel BBB-penetrating Systems, Ocular Eye-drop Systems, and Tumor Tissue-targeted Intracellular Approaches - Daiichi Sankyo
Closes 16th March 2026
ASO and siRNA Therapeutics for CNS and Liver Disorders - Nissan Chemical Corporation
Closes 5th March 2026
Seeking Novel Disease Models of Macular Degeneration - Daiichi Sankyo
Closes 2nd March 2026
Cell-free Synthesis of Transfection-grade Plasmid DNA for Automated Processing - Daiichi Sankyo
Closes 2nd March 2026
High Throughput Screening Assays to Map Macrocyclic Peptide Permeability and Stability Properties - AstraZeneca
Closes 6th March 2026
AI/ML-ready Datasets for Peptide Permeability & Oral Bioavailability or Macrocyclic Peptide Screening Libraries to Enable Oral, Cell-permeable Macrocycle Design - AstraZeneca
Closes 6th March 2026
Non-canonical Amino Acids for in vitro Display Systems - AstraZeneca
Closes 6th March 2026
Reducing Organic Impurities in Phosphoric Acid Production - ICL Group
Closes 26th February 2026
*Campaigns with geographic restrictions may not be shown here